What does the evidence say about Chlorella Blood Pressure Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Chlorella Blood Pressure Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - vulgaris) consumption on cardiovascular disease risk factors in patients with non-alcoholic fatty liver disease (NAFLD). [Jafari A (2026); evidence level 1] - However, all included studies were conducted in Iran, limiting the generalizability of these findings, and the certainty of evidence was rated as very low due to risk of bias, indicating that the results should be interpreted with caution. [Jafari A (2026); evidence level 1] - This systematic review and meta-analysis aimed to assess the impact of Chlorella vulgaris (C. [Jafari A (2026); evidence level 1] - Chlorella 5 7 8 9 10 Emerging evidence suggests that supplementation withand spirulina may be associated with improvements in metabolic parameters such as insulin sensitivity, lipid profiles, and hepatic steatosis markers while simultaneously reducing systemic inflammatory burden and oxidative stress. [Rzeski Wojciech (2026); evidence level 3] - We also discuss clinical evidence, safety considerations, and translational perspectives, highlighting current knowledge gaps and future research directions necessary for the rational development of microalgae-based interventions in preventive and integrative medicine. [Rzeski Wojciech (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.